After completing his M.D. and Ph.D. at the University of Pisa, Gennaro De Libero joined the Max Planck Institute for Immunobiology in 1984 as a postdoctoral fellow in Professor Stefan Kaufman's laboratory, supported by a long-term EMBO fellowship. In 1988, he moved to the Basel Institute of Immunology and, in 1990, to the Faculty of Medicine at the University of Basel, where he took responsibility for the Experimental Immunology Group and was appointed as full Professor of Immunology. From 2010 to 2016, he served as Director of the Tuberculosis Unit at the Singapore Immunology Network.

Melissa Little, AC, is CEO of the Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Chief Scientist at the Murdoch Children’s Research Institute, and leads the Kidney Regeneration Laboratory in Melbourne. She is globally recognized for pioneering kidney organoid technology using human pluripotent stem cells, which is applied in disease modeling, drug screening, and renal replacement therapies.

In 2009, Oliver Bannard completed his PhD under the supervision of Professor Douglas Fearon at the University of Cambridge, UK, investigating the developmental pathway of memory CD8+ T cells. Subsequently, he joined Professor Jason Cyster's laboratory at the University of California, San Francisco (UCSF), supported by a Wellcome Trust-funded postdoctoral fellowship, where his focus shifted to B cell research. In 2015, Prof. Bannard returned to the UK to establish an independent research group at the Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford.